Botanix Pharmaceuticals (ASX:BOT) announced the appointment of Howie McKibbon as its CEO.
The company further announced that they are targeting the FDA approval of Sofpironium Bromide for the end of September 2023.
Botanix Pharmaceuticals is a company that engages in drug development targeting areas of serious human diseases.
Global online trading services company, Plus500:
Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.
Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.
Receive whispers every day in your inbox.
